Does the combination of photobiomodulation therapy (PBMT) and static magnetic fields (sMF) potentiate the effects of aerobic endurance training and decrease the loss of performance during detraining? A randomised, triple-blinded, placebo-controlled trial

Table 3 Progressive endurance test variables in absolute values

	Baseline	4 weeks	8 weeks	12 weeks	16 weeks
Time until exhaustion (sec)
PBMT/sMF + PBMT/sMF	767.29 ± 77.58	887.86 ± 81.37	921.21 ± 101.07	986.86 ± 125.53	932.57 ± 110.46
PBMT/sMF + Placebo	812.53 ± 121.46	934.35 ± 134.16	980.24 ± 149.28	1025.65 ± 165.58	915.53 ± 147.63
Placebo + PBMT/sMF	853.54 ± 146.12	906.5 ± 167.54	949.25 ± 176.76	961 ± 153.46	940.06 ± 142.37
Placebo + Placebo	801.67 ± 122.49	855.83 ± 134.66	853 ± 119.39	892.67 ± 155.03	823.08 ± 160.85
VO_{2 max} (mL/kg/min)
PBMT/sMF + PBMT/sMF	21.94 ± 2.71	30.81 ± 4.38^*	30.87 ± 4.49^*	30.64 ± 4.98^*	30.26 ± 5.42^**
PBMT/sMF + Placebo	24.91 ± 6.08	32.06 ± 8.53^**	33.48 ± 7.97^***	33.34 ± 9.13^***	29.46 ± 8.16^*
Placebo + PBMT/sMF	24.61 ± 6.14	26.93 ± 7.25	28.27 ± 6.41	27.4 ± 5.51	28.15 ± 5.44
Placebo + Placebo	22.06 ± 5.12	24.68 ± 4.96	24.89 ± 5.60	24.34 ± 5.24	22.38 ± 5.31
Fat percentage
PBMT/sMF + PBMT/sMF	24.55 ± 10.64	22.61 ± 9.07	22.3 ± 8.74	21.59 ± 9.58	20.84 ± 8.65
PBMT/sMF + Placebo	26.16 ± 6.46	25.39 ± 7.31	25.19 ± 6.7	24.85 ± 7.21	25.2 ± 7.98
Placebo + PBMT/sMF	18.8 ± 10.39	17.83 ± 10.00	17.62 ± 10.00	16.96 ± 9.14	17.24 ± 9.19
Placebo + Placebo	21.05 ± 9.60	20.29 ± 9.24	19.91 ± 8.89	19.43 ± 8.56	19.13 ± 8.53

Data are expressed as means and standard deviations (±). VO₂ max: maximum oxygen uptake. ^* indicates a statistically significant difference compared to Placebo+Placebo (p < 0.05), ^** indicates a statistically significant difference compared to Placebo+Placebo (p < 0.01), ^*** indicates a statistically significant difference compared to Placebo+Placebo (p < 0.001)

ISSN: 2052-1847